This hypothesis is supported by the fact that DCK up-regulation induced by retroviral transduction with the DCK vector was able to sensitize non-malignant MCF 10A and malignant HCC1954 BC cells to DAC and gemcitabine (Geutjes et al., 2012). This evidence concerns the gene DCK and breast cancer.